Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
HCP Jobs
Contact Us
EMJ Gold
search
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
HCP Jobs
Contact Us
EMJ Gold
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
4
Mins
3rd August 2017
Helsinn Group and MEI Pharma Announce First Patient Dosed in Pivotal Phase 3 Study of Pracinostat and Azacitidine in Acute Myeloid Leukemia
Lugano, Switzerland and San Diego, USA, 2 August, 2017 – Helsinn, a Swiss pharmaceutical group focused on building quality cancer care products…
2
Mins
3rd August 2017
Introducing EMJ Allergy & Immunology 2.1
United Kingdom, August 03, 2017: EMJ would like to welcome you to the latest edition of EMJ Allergy and Immunology. This much-anticipated eJournal…
14
Mins
3rd August 2017
Review of the 61st European Academy of Allergy and Clinical Immunology Congress 2017
The largest allergy congress in the world was this year hosted in the scenic city of Helsinki, Finland.
2
Mins
1st August 2017
Introducing EMJ Rheumatology 4.1
United Kingdom, August 01, 2017: A warm welcome to EMJ Rheumatology 4.1, a journal that aims to bring healthcare professionals up to date on the latest…
31st July 2017
EULAR 2017 – Congress Highlights
Our full congress review of EULAR 2017 is out now! Find it for free in our Rheumatology 4.1 eJournal. Take a look at some of the sights from this year’s…
1
Mins
26th July 2017
Neurodegeneration Biomarkers for Diagnosis of Alzheimer’s and MND
26 July, 2017 – A portfolio of CSF biomarkers corresponding to different stages of the neurodegenerative process aids diagnosis of Alzheimer’s disease…
1
Mins
26th July 2017
Comprehensive Serological Diagnostics in Neurology
26 July, 2017 – Neurological disorders, including memory deficits, psychosis and seizures, can be caused by underlying autoimmune reactions.
3
Mins
25th July 2017
ANTABIO Awarded Up to $8.9M from CARB-X to Accelerate the Development of Its New Treatment For Chronic Infections in Cystic Fibrosis Patients
Labège, France, 25 July, 2017 – Antabio SAS, a biopharmaceutical company developing novel antibacterial treatments in areas of highest unmet needs…
2
Mins
24th July 2017
Orchard Therapeutics Announces That OTL-101 Has Received a Rare Paediatric Disease Designation
London, UK, 24 July, 2017 – Orchard Therapeutics Limited (“Orchard”), a clinical-stage biotechnology company dedicated to bringing transformative…
5
Mins
18th July 2017
RedHill Biopharma Announces Last Patient Visit in BEKINDA® Phase II Study for IBS-D
Tel-Aviv, Israel / Raleigh, NC, USA, 17 July, 2017 – RedHill Biopharma Ltd. (NASDAQ: RDHL) (Tel-Aviv Stock Exchange: RDHL) (“RedHill” or the “Company”)…
←
1
2
3
…
32
33
34
35
36
37
38
…
151
152
153
→